Drug Shortage Bill Would Stem 340B Discounts Through 2020

by Admin | November 30, 2012 4:44 pm

November 30, 2012—Legislation that aims to address drug shortages by exempting manufacturers from providing 340B discounts on certain pharmaceuticals has been introduced in the U.S. House.

Rep. Bill Cassidy (R-La.), a member of the House Energy and Commerce Subcommittee on Health, introduced the Patient Access to Drugs in Shortage Act (H.R. 6611)[1] late yesterday. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Patient Access to Drugs in Shortage Act (H.R. 6611): http://cassidy.house.gov/press-release/cassidy-proposes-drug-shortage-solutions
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2012/11/drug-shortage-bill-would-stem-340b-discounts-through-2020/

Copyright ©2026 340binformed.org unless otherwise noted.